Cohbar (CWBR)
(Delayed Data from OTC)
$0.80 USD
-0.06 (-6.98%)
Updated May 2, 2024 11:25 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Cohbar Inc. [CWBR]
Reports for Purchase
Showing records 1 - 19 ( 19 total )
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
We are reiterating our Buy rating and 12-month Price Target of $8/share of CohBar.
Provider: Roth Capital Partners, Inc.
Analyst: PIROS E
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
You Are Invited to Our Virtual 33rd Annual ROTH Conference on March 15-17, 2021
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
EVENT: COVID-19 Therapeutics in Development: Beyond Gilead, Regeneron and Lilly
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Final Program for Our Fourth Annual Virtual NASH Investor Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Company: Cohbar Inc.
Industry: Medical - Biomedical and Genetics
Harnessing the Power of Mitochondrial Peptides -Initiation of Coverage
Provider: Roth Capital Partners, Inc.
Analyst: PIROS E
Company: Cohbar Inc.
Industry: Unclassified
Agenda for Our First Annual NASH Investor Conference on April 3 in NY
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
|